Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIV
3HP-LTBI
2 other identifiers
interventional
50
1 country
2
Brief Summary
Tuberculosis (TB) is the prototypical disease of poverty as it disproportionately affects marginalized and impoverished communities. In the US, TB rates are unacceptably high among homeless persons who have a 10-fold increase in TB incidence as compared to the general population. In California, the rate of TB is more than twice the national case rate and recent TB outbreaks have been alarming. Among persons with active TB disease, over 10% die during treatment, with mortality being even higher among homeless persons with TB. While TB can be prevented by treating TB infection (TBI) before it develops into infectious, symptomatic disease, individual factors such as high prevalence of psychosocial comorbidities, unstable housing and limited access to care have led to poor adherence and completion of TBI treatment among homeless persons. Given the complex health disparity factors that affect TBI treatment adherence among homeless persons, this study will assess the feasibility of a theoretically-based novel model of care among persons with TBI and complex chronic illnesses. This study will evaluate an innovative, community-based intervention that addresses critical individual level factors which are potential mechanisms that underlie health disparities in completing TBI treatment among the predominantly minority homeless. The study hypothesis is that improving these conditions, and promoting health by focused screening for TBI, and early detection and treatment for these vulnerable adults will improve TB treatment completion and prevent future TB disease. The proposed theoretically-based health promotion intervention focuses on: 1) completion of TBI treatment, 2) reducing substance use; 3) improving mental health; and 4) improving critical social determinants of TB risk (unstable housing and poor health care access) among homeless adults in the highest TB prevalence area in Los Angeles. A total of 76 homeless adults with TBI will receive this program which includes culturally-sensitive education, case management, and directly observed therapy (DOT) delivery of medication among patients who have been prescribed 3HP (12 weeks treatment for latent TB infection) by a medical provider. This study will determine whether this intervention can achieve higher completion rates than the 65% completion rate among homeless persons reported by previous TB programs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2018
CompletedFirst Posted
Study publicly available on registry
October 10, 2018
CompletedStudy Start
First participant enrolled
January 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 4, 2020
CompletedResults Posted
Study results publicly available
April 18, 2024
CompletedApril 18, 2024
March 1, 2024
1.3 years
October 8, 2018
January 2, 2024
March 21, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Completion of TBI Treatment
Completion of TBI Treatment will be measured at 3 month follow-up by 90% completion of medication (at least 11/12 doses) consumed over a 12 week period
3 months (12 weeks)
Secondary Outcomes (5)
Drug Use
baseline, 3 and 6 months
Alcohol Use
baseline, 3 and 6 months
Depression
baseline, 3 and 6 months
Health Care Access
3 and 6 months
Shelter Stability - Days Residing in the Shelter
3 and 6 months
Study Arms (1)
RN/CHW TBI
EXPERIMENTALNurse-led Community Health Worker TBI (RN/CHW TBI) program
Interventions
Homeless adults with TBI will be assigned to this program which includes culturally-sensitive education, case management, and directly observed therapy (DOT) delivery of medication among patients who have been prescribed 3HP (12 weeks treatment for latent TB infection) by a medical provider. For this research, 3HP will be delivered to homeless persons infected with TB on a weekly basis by CHW under the guidance of their RN. The RN/CHW team will also provide case management, including health education and referrals for social services.
Eligibility Criteria
You may qualify if:
- self-reported homeless adults (past six months);
- age 18 or older;
- willing to provide informed consent;
- positive for TBI
- reported current or recent substance use (past three years)
You may not qualify if:
- screened as having active TB or currently treated for TBI;
- history of treatment for active TB or TBI;
- a serum aspartate aminotransferase (AST) level of 3-5 times the upper limit of normal;
- HIV infected AND receiving antiretroviral therapy (as 3HP is not recommended yet in this group);
- not able to speak English or Spanish;
- testing pregnant (as 3HP is not recommended in this group); and
- judged to be cognitively impaired
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Los Angeles Christian Health Centers (LACHC)
Los Angeles, California, 90013, United States
Union Rescue Mission
Los Angeles, California, 90013, United States
Related Publications (1)
Nyamathi A, Salem BE, Shin SS, Jones AA, Garfin DR, Yadav K, Chang AH, White K, Morisky D. Effect of a Nurse-Led Community Health Worker Intervention on Latent Tuberculosis Medication Completion Among Homeless Adults. Nurs Res. 2021 Nov-Dec 01;70(6):433-442. doi: 10.1097/NNR.0000000000000545.
PMID: 34380979DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Adeline M Nyamathi
- Organization
- University of California, Irvine, Sue & Bill Gross School of Nursing
Study Officials
- PRINCIPAL INVESTIGATOR
Adeline M Nyamathi, PhD
University of California, Irvine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Founding Dean and Distinguished Professor
Study Record Dates
First Submitted
October 8, 2018
First Posted
October 10, 2018
Study Start
January 24, 2019
Primary Completion
May 29, 2020
Study Completion
September 4, 2020
Last Updated
April 18, 2024
Results First Posted
April 18, 2024
Record last verified: 2024-03